Barrier Therapeutics
Latest round
- Series C
Last raised
- Oct 2003
Total raised
- $78M
Investors
- 7
About Barrier Therapeutics
Barrier Therapeutics is a pharmaceutical company focused on developing innovative treatments for dermatological conditions.Barrier Therapeutics was founded in 2002 in Princeton, US, and operates as a subsidiary under Stiefel Laboratories. The company had five deals, with the most recent deal occurring on April 1, 2004.Barrier Therapeutics primarily offers products that target various dermatological issues, addressing significant health challenges.08 mn.Barrier Therapeutics is focused on expanding its product line with new dermatological therapies, although specific upcoming products or launch dates have not been disclosed. The company also aims to broaden its presence in new markets, particularly targeting regions with unmet dermatological needs.
Who invested in Barrier Therapeutics
7 investors across 2 rounds
See all investors in Barrier Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Barrier Therapeutics
Who invested in Barrier Therapeutics?
Barrier Therapeutics has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Barrier Therapeutics raised?
Barrier Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Barrier Therapeutics last raise money?
Barrier Therapeutics's most recent round on record is a Series C, in Oct 2003.
What does Barrier Therapeutics do?
Barrier Therapeutics is a pharmaceutical company focused on developing innovative treatments for dermatological conditions.
Where is Barrier Therapeutics headquartered?
Barrier Therapeutics is headquartered in Princeton, US.
Which VCs invest in companies like Barrier Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Barrier Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Barrier Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.